A recent study published in the journal BMJ Medicine examined the effects of microdosing psychedelics on depression and anxiety, comparing them to a placebo. The research, led by Balázs Szigeti from Imperial College London, involved participants who self-supplied substances like psilocybin truffles and followed their own dosing schedules. The study found that both the microdosing group and the placebo group experienced significant reductions in depression and anxiety symptoms, with no statistically significant difference between them. This suggests that the benefits may be largely attributed to the placebo effect or the ritual of microdosing itself, rather than the pharmacological action of the drugs. The findings highlight the need for more rigorous, controlled clinical trials to determine any true therapeutic effect. Read the full article at: https://www.wired.com/story/microdosing-for-depression-appears-to-work-about-as-well-as-drinking-coffee/